Human Genome Sciences Sees Reality Take (HGSI)
Posted in pre-marketAugust 31st, 2009
Human Genome Sciences, Inc. (NASDAQ: HGSI) is getting clipped this morning as the hopes of the buyout settle down on the realization that large drug companies might not want to pay up over and above a more than tenfold rise in shares. HGSI is down almsot 3% at $19.32 on about 30,000 shares as of 8:50 AM EST. Average volume now is over 12 million shares and the recent post-hype high is $22.78. -JON OGG
VS Investor RSS Feed